The Effects of Sodium-Glucose Cotransporter 2-Inhibitors on Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease or Steatohepatitis and Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials

Type 2 Diabetes Mellitus (T2DM) and non-alcoholic fatty liver disease (NAFLD) are part of metabolic syndrome and share multiple causal associations. Both conditions have an alarmingly increasing incidence and lead to multiple complications, which have an impact on a variety of organs and systems, su...

Descripción completa

Detalles Bibliográficos
Autores principales: Bica, Ioana-Cristina, Stoica, Roxana Adriana, Salmen, Teodor, Janež, Andrej, Volčanšek, Špela, Popovic, Djordje, Muzurovic, Emir, Rizzo, Manfredi, Stoian, Anca Pantea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301940/
https://www.ncbi.nlm.nih.gov/pubmed/37374340
http://dx.doi.org/10.3390/medicina59061136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301940/
https://www.ncbi.nlm.nih.gov/pubmed/37374340
http://dx.doi.org/10.3390/medicina59061136

Ejemplares similares